Nautilus Advisors LLC

Position in ABBV — AbbVie Inc.

CIK 2083253 La Jolla, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,885,035

+$57,902 QoQ

Shares Held

7,491

-10.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.85%

of 13F equity value

Holder Rank

#2,014

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nautilus Advisors LLC holds $5,916,229 across 6 Drug Manufacturers - General names. ABBV ranks #1 (31.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	7,491	$1,885,035
2	JNJ	Johnson & Johnson	4,260	$1,081,912
3	GILD	Gilead Sciences, Inc.	7,021	$887,033
4	AMGN	Amgen Inc	2,048	$741,621
5	BMY	Bristol Myers Squibb Co	12,345	$711,318
6	LLY	ELI LILLY & Co	508	$609,310

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,885,035	7,491	-10.8%	Shares	Sole	2026-07-14
2026-03-31	$1,827,133	8,401	-1.7%	Shares	Sole	2026-04-17
2025-12-31	$1,953,132	8,548	-1.1%	Shares	Sole	2026-01-22
2025-09-30	$2,001,431	8,644	+3.8%	Shares	Sole	2025-11-12
2025-06-30	$1,545,657	8,327	+14.7%	Shares	Sole	2025-08-26
2025-03-31	$1,521,534	7,262	+0.0%	Shares	Sole	2025-08-26
2024-12-31	$1,290,102	7,260	—	Shares	Sole	2025-08-26
No filing history on record for this holder in this stock.